Toll-like receptor 2: Therapeutic target for gastric carcinogenesis

• Main Authors: McCormack, W., Oshima, M., Tan, P., Jenkins, B.J.
• Other Authors: DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
• Format: Editorial
• Published: Impact Journals LLC 2014
• Subjects: antineoplastic agent; cisplatin; epirubicin; fluorouracil; myeloid differentiation factor 88; opn 301; small interfering RNA; toll like receptor 2; unclassified drug; advanced cancer; antineoplastic activity; cancer inhibition; cancer recurrence; cancer size; cancer survival; chronic inflammation; drug efficacy; drug mechanism; drug safety; editorial; gene amplification; gene overexpression; gene targeting; human; intracellular signaling; nonhuman; overall survival; somatic mutation; stomach cancer; stomach carcinogenesis; strategic planning; survival rate; toll like receptor 2 gene; upregulation
• Online Access: http://scholarbank.nus.edu.sg/handle/10635/110365

Oncotarget